Accéder au contenu
Merck

Oxcarbazepine in neuropathic pain.

Expert opinion on investigational drugs (2007-10-10)
Wassim Nasreddine, Ahmad Beydoun
RÉSUMÉ

Neuropathic pain is a frequent condition that can result from a variety of underlying conditions and is frequently chronic and difficult to treat. A number of drugs are used to treat neuropathic pain, including anticonvulsants and antidepressants. Oxcarbazepine, a recently introduced antiepileptic drug, was found to possess antineuralgic properties in animal models of neuropathic pain. Several double-blind, placebo-controlled trials have evaluated oxcarbazepine in painful diabetic neuropathy and trigeminal neuralgia. There is good evidence that oxcarbazepine is effective in relieving the pain associated with trigeminal neuralgia. Its efficacy in treating painful diabetic neuropathy is less clear; however, it seems to be useful when tolerated at doses of 1800 mg/day.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Oxcarbazepine, ≥98% (HPLC), solid
Supelco
Oxcarbazepine solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
USP
Oxcarbazepine, United States Pharmacopeia (USP) Reference Standard
Oxcarbazepine, European Pharmacopoeia (EP) Reference Standard